Medical injector with coupled body portions
4 claims: 2 independent, 2 dependent
- 1An injection device (10) comprising:first and second body portions (12, 14) each having a longitudinal axis (L1, L2);an axially-displaceable plunger (28);and biasing means (30) for advancing said plunger a predetermined distance, wherein said first and second body portions (12, 14) are configured to couple together at a coupling (16), said first and second body portions being complementarily formed so as to be movable about said coupling, a reservoir (46) is disposed within the first body portion (12), the plunger (28) is located within the second body portion (14) in said initial state and the injection device (10) further comprises a releasable retainer (32) for releasably retaining the plunger in a first state against the force of the biasing means, wherein, in an initial state, said axes (L1, L2) of said first body portion and said second body portion are not axially aligned, and said plunger is in said first state, and in a coupled state, said axes (L1, L2) of said first and second body portions are axially aligned thereby allowing said biasing means to advance said plunger said predetermined distance when said releasable retainer releases said plunger, characterized in that said axes (L1,L2) of said first body portion and said second body portion are essentially parallel to one another in said initial state.
Independent claims2
38 paragraphs in 5 sections, as filed
FIELD OF THE INVENTION
0001This invention relates to medical injectors, and, more particularly, to medical injectors having plunger drive mechanisms.
BACKGROUND QF THE INVENTION
0002Medical injectors are well known in the prior art, including injectors which have internal drive mechanisms for plunger advancement. Plunger advancement may be utilized to conduct automated reconstitution of a two-or more part medicament and/or to cause automated injection. More specifically, the automation of plunger advancement may be utilized to cause combination of a multiple part (e.g., wet/dry) medicament. In addition, or alternatively, the automated advancement of the plunger may cause a needle to be advanced for injection and/or medicament to be driven through the needle during injection. Such automated action requires a trigger mechanism. Concerns exist over premature or failed trigger activation.
0003<patcit id="pcit0001" dnum="WO2005077441A2"><text>WO 2005/077441 A2</text></patcit> describes an injection device according to the preamble of claim 1. J
SUMMARY OF THE INVENTION
0004A medical injector is provided according to the appended claims. Advantageously, the subject invention provides a medical injector having an automated plunger drive which is triggered upon assembly of the pen injector, thereby minimizing premature or failed activations.
0005These and other features of the subject invention will be better understood through a study of the following detailed description and accompanying drawings.
BRIEF DESCRIPTION QF THE DRAWINGS
0006<ul id="ul0001" list-style="none"><li><figref idref="f0001">Figures 1</figref> and <figref idref="f0003">2</figref> show a medical injector in pre-assembled and assembled states, respectively; <figref idref="f0003">Figure 2</figref> shows a coupled state according to the appended claims;</li><li><figref idref="f0002">Figures 3</figref> and <figref idref="f0003">4</figref> are cross-sectional views of a medical injector formed in accordance with the subject invention, as defined by the appended claims;</li><li><figref idref="f0004">Figure 5</figref> is a schematic of a releasable retainer useable with the subject invention, as defined by the appended claims;</li><li><figref idref="f0005">Figure 6</figref> is a cross-sectional view of a medical injector formed in accordance with the subject invention, as defined by the appended claims, having a reservoir configured for reconstitution;</li><li><figref idref="f0006">Figures 7 and 8</figref> show an arrangement for achieving relative movement of components;</li><li><figref idref="f0007">Figure 9</figref> is an exploded view of components useable with the subject invention, as defined by the appended claims;</li><li><figref idref="f0004">Figure 10</figref> is a cross-sectional view taken along line 10-10 of <figref idref="f0007">Figure 9</figref>;</li><li><figref idref="f0008">Figure 11</figref> is a perspective view of a dose knob useable with the subject invention, as defined by the appended claims;</li><li><figref idref="f0009">Figure 12</figref> is an exploded view of the subject invention, as defined by the appended claims;</li><li><figref idref="f0008 f0010">Figures 13-16</figref> show operation of a medical injector formed in accordance with the subject invention, as defined by the appended claims; and</li><li><figref idref="f0011 f0012">Figures 17-20</figref> show cap configurations useable with the subject invention, as defined by the appended claims;</li></ul>
DETAILED DESCRIPTION OF THE INVENTION
0007With reference to the figures, a medical injector is shown and generally designated with the reference numeral 10. The medical injector 10 may be of various types, but preferably is of the pen injector type. The medical injector 10 may be used to administer various injectable liquids, particularly medicaments.
0008With reference to <figref idref="f0001">Figure 1</figref>, the medical injector 10 includes first and second body portions 12, 14 which are connected through a movement relative to coupling 16. Preferably, the coupling 16 is a hinged connection. The first and second body portions 12, 14 are complementarily formed so as to be assembled together with sufficient movement, e.g., rotation, about the coupling 16. As shown in <figref idref="f0001">Figure 1</figref>, longitudinal axes L1, L2 of the first and second body portions 12, 14 are not axially (not collinearly) aligned in a state of the medical injector 10. The coupled state of the medical injector 10 is shown in <figref idref="f0003">Figure 2</figref> where the longitudinal axes L1, L2 are axially aligned.
0009The first and second body portions 12, 14 are preferably formed of rigid material and to varying extents accommodate different portions of the medical injector 10. Preferably, to facilitate assembly, as shown in <figref idref="f0002">Figure. 3</figref>, a reduced diameter portion 18 is formed on one of the first and second body portions 12, 14 with a corresponding telescoping portion 20 being formed on the other of the first and second body portions 12, 14. In this manner, the first and second body portions 12, 14 may be assembled with the telescoping portion 20 being disposed over the reduced diameter portion 18. In addition, cooperating locking elements 22, such as cooperating detent and groove, meshing teeth, and/or other snap-together locking features, may be provided to lock the first and second body portions 12, 14 together once assembled.
0010As shown in the figures, particularly <figref idref="f0006">Figures 7 and 8</figref>, the coupling 16 may be a pin hinge where brackets 24 are provided on the first and second body portions 12, 14 which are joined together to rotate about a central pin 26. As will be appreciated by those skilled in the art, a living hinge may also be used for the coupling 16. The coupling 16 is positioned and formed to allow proper movement, e.g., rotation, thereabout in allowing the first and second body portions 12, 14 to come together and form the medical injector 10.
0011The medical injector 10 includes an axially-displaceable plunger 28. The plunger 28 may be formed as a single piece or by modular components. The modular components may be fixed to one another or located adjacently, but not connected, so as to move together. In a preferred embodiment, the plunger 28 is initially located in the second body portion 14. A biasing element 30 is also provided configured and positioned to advance the plunger 28 a predetermined distance. Preferably, the biasing element 30 is a compression or coil spring, but other biasing elements may likewise be utilized. Preferably, the biasing element 30 is positioned in the second body portion 14.
0012A releasable retainer 32 is provided configured and positioned to releasably retain the plunger 28 in an initial first state against the force of the biasing element 30. The releasable retainer 32 is configured such that, upon assembly of the first and second body portions 12, 14, the releasable retainer 32 releases the plunger 28 thereby allowing the biasing element 30 to advance the plunger 28 the predetermined distance. As will be appreciated by those skilled in the art, various releasable retainers may be used with the subject invention.
0013It is preferred that the plunger 28 be advanced in a distal direction. As used herein, distal refers to a direction towards a patient during use, while proximal refers to a direction away from a patient during use.
0014By way of non-limiting example, the releasable retainer 32 may be a displaceable cam member 34, as shown in <figref idref="f0002 f0003 f0004">Figures 3-5</figref>. As shown in <figref idref="f0002">Figures 3</figref> and <figref idref="f0003">4</figref>, upon assembly of the first and second body portions 12, 14, a cam arm 36 may be displaced, such as by interfering engagement with a portion or component of the first body portion 12, thus causing displacement of the cam member 34. The cam member 34 may include a protruding stop member 38 formed to interferingly engage a portion of the plunger 28, such as shoulder 40, in causing retention thereof in an initial, first state, before use. With displacement of the cam member 34, the cam member 34 releases the shoulder 40 thus allowing the biasing element 30 to drive the plunger 28 distally. It is preferred that the cam member 34 be pivotally connected to the second body portion 14, so as to be rotatable relative thereto. Displacement of the cam member 34 may be achieved by interengagement of ramped surface 42 of the cam arm 36 acting against engagement surface 44 of the cam member 34 under movement of the cam arm 36 resulting in sufficient rotation of the cam member 34 to clear the stop member 38 from the shoulder 40.
0015The medical injector 10 includes a reservoir 46 disposed in the first body portion 12 formed to accommodate medicament or other substance 48 for injection into a patient. As shown in <figref idref="f0002">Figure 3</figref>, the reservoir 46 may be a single chamber disposed in a barrel 50 sealed at a proximal end by a septum 52 and sealed at a distal end by a stopper 54 which is formed to be slidable through the barrel 50 for urging the substance 48 therefrom, as known in the art. The medical injector 10 also includes a needle mounting surface 56 having features 58 formed thereon for mounting a needle 60 thereto. The needle 60 may include a hub 62 having mounting features 64 provided thereon for cooperative engagement with the features 58 in mounting the needle 60 to the needle mounting surface 56. The features 58 and the mounting features 64 may be of any known cooperating elements which permit a mechanical connection therebetween, such as threads or bayonet lock, and/or a frictional interengagement, such as a Luer mounting. The needle mounting surface 56 may be formed on the first body portion 12 or a component thereof.
0016The needle 60 also includes a needle cannula 61 having a distal end 63, formed for insertion into a patient, and a proximal end 65.
0017The reservoir 46 may be configured to accommodate multiple components which are mixable for reconstitution. For example, as shown in <figref idref="f0005">Figure 6</figref>, the reservoir may accommodate first and second mixable components 66, 68. The stopper 54 may be associated with the reservoir 46 such that distal advancement of the stopper 54 over a predetermined distance shall cause mixing of the first and second mixable components 66, 68. Any known arrangement for allowing such mixing may be utilized. By way of non-limiting example, the first and second mixable components 66, 68 may be separated by a secondary stopper 70. The secondary stopper 70 divides the reservoir 46 into first and second chambers 72, 74, respectively, accommodating the first and second mixable components 66, 68. The septum 52 seals off the distal end of the first chamber 72, while the stopper 54 is positioned to seal off the proximal end of the second chamber 74. Preferably, if a dry component is used as one of the mixable components, the dry mixable component is located in the first chamber 72.
0018One or more by-pass channels 76 are formed in the wall of the reservoir 46. In an initial state, as shown in <figref idref="f0005">Figure 6</figref>, the secondary stopper 70 is located at least partially proximally of the by-pass channels 76 so as to define a seal between the first and second chambers 72, 74 and to define a seal between the second chamber 74 and the by-pass channels 76. With distal advancement of the stopper 54, and with the second mixable component 68 being wet and generally incompressible, force of movement of the stopper 54 is transmitted to the secondary stopper 70 through the second mixable component 68. With sufficient distal movement of the secondary stopper 70, the second chamber 74 comes into communication with the by-pass channels 76, thus allowing the second mixable component 68 to be urged into the first chamber 72 with further distal movement of the stopper 54. With sufficient distal advancement of the stopper 54, the second chamber 74 is collapsed with none or substantially none of the second mixable component 68 remaining therein. In addition, the secondary stopper 70 is located so as to define a seal between the first chamber 72 and the by-pass channels 76. The first and second mixable components 66, 68 are mixed within the first chamber 72, such as through agitation of the medical injector 10, so as to produce the injectable substance 48, ready for injection.
0019The barrel 50 of the reservoir 46 may be the barrel of a separate drug cartridge, as shown in the figures, or a portion of the medical injector 10, particularly the first body portion 12.
0020As will be recognized by those skilled in the art, other arrangements for permitting reconstitution may be utilized. In addition, more than two-part systems, such as three-part and so forth, systems may be utilized. Active medical ingredients may be included in one or both of the first and second mixable components 66, 68. The first mixable component 66 may be dry (e.g., a powder or granular substance) and/or a liquid (e.g., flowable (slurry or liquid)). As mentioned above, the second mixable component 70 is preferably only a wet flowable component, such as a liquid or slurry.
0021Distal advancement of the plunger 28 under force of the biasing element 30 may be used to achieve one or more objectives. The plunger 28 is configured to act against the stopper 54 and cause displacement thereof. With the reservoir 46 being configured for reconstitution, autoreconstitution of the contents of the reservoir 46 may be achieved. In addition, or alternatively, the medical injector 10 may be configured to be an autoinjector, where the needle 60 is initially housed within the first body portion 12 and forced thereout of under force of the biasing element 30 so as to pierce a patient's skin, e.g., with forward movement of the reservoir 46, as known in the art. In addition, or alternatively, distal advancement of the plunger 28 may cause administration of the contents of the reservoir 46 through the injected needle.
0022Depending on the desired effect, the medical injector 10 may be configured to have the plunger 28 be driven a predetermined distance. A physical stop, such as interengagement between the shoulder 40 and a proximal end 78 of the reservoir 46 (e.g., proximal end of the barrel 50), may be employed to limit distal advancement of the plunger 28. Under certain circumstances, the plunger 28 may be distally advanced without the needle 60 being mounted to the medical injector 10. Thus, the reservoir 46 is not vented during such action. With the needle 60 being subsequently mounted to the reservoir 46, any residual gases trapped in the reservoir 46 are purged through the needle 60. It may be preferred to not provide a physical stop to the distal advancement of the plunger 28. In this manner, the contents of the reservoir 46 may be maximally compressed under force of the biasing element 30. With subsequent mounting of the needle 60 onto the medical injector 10, the reservoir 46 is vented thus permitting further distal advancement of the plunger 28. This secondary distal advancement may assist in priming the needle 60 for use.
0023<figref idref="f0005">Figure 6</figref> shows the medical injector 10 in a state prior to use. As shown therein, the reservoir 46 may be a drug cartridge which is separable from the first body portion 12. One or more cartridge retaining hooks 80 may be provided to act against the barrel 50 in holding the barrel 50 in the first body portion 12. It is preferred that the cartridge retaining hooks 80 be resilient so as to permit outward deflection in loading the reservoir 46 into the first body portion 12.
0024It is preferred that a cartridge retaining element 82 be provided which includes a sleeve 84 into which the reservoir 46 is disposed. In addition, it is preferred that the needle mounting surface 56 and the cartridge retaining hooks 80 be formed on the cartridge retaining element 82. The cartridge retaining element 82 may be retained in the first body portion 12 through any known fixing arrangement, such as a mechanical connection, e.g., snap engagement or frictional connections, and/or chemical or adhesive connections, such as fusion, welding or gluing.
0025Movement of one or more of the components relative to the first and/or second body portions 12, 14 may be desired. To obtain such relative movement, with reference to <figref idref="f0006">Figures 7 and 8</figref>, a pinion 86 may be mounted to one of the first and second body portions 12, 14 with a corresponding rack 88 being mounted to the component intended for relative movement. As shown in the Figures, the cartridge retaining element 82 may be configured for movement relative to the first body portion 12. To this end, the cartridge retaining element 82 may be nested within the first body portion 12 with the rack 88 being located thereon. The pinion 86 and the rack 88 are formed with teeth 87, 89 formed for cooperating meshing engagement. With movement about the coupling 16, the pinion 86 rotates and causes linear translation of the rack 88, thus causing the cartridge retaining element 82 to translate relative to the first body portion 12. This linear translation permits for various axial adjustments of the reservoir 46, or other components. The needle mounting surface 56 may be formed on the cartridge retaining element 82 and caused to be initially hidden in the first body portion 12 with subsequent distal advancement through translation of the cartridge retaining element 82 causing the needle mounting surface 56 to become exposed (<figref idref="f0003">Figure 2</figref>).
0026In this manner, control can be established over proper timing of the needle mounting surface 56 during sequence of preparation of the medical injector 10. In particular, it may be desired to expose the needle mounting surface 56 only after reconstituting, if reconstitution is utilized.
0027The medical injector 10 may be a fixed dose injector configured to administer single or multiple fixed doses. In addition, the medical injector 10 may be configured to permit dose setting for either a single or multiple doses. In a preferred embodiment, the medical injector 10 is a single, variable-dose autoreconstitution injector.
0028As will be appreciated by those skilled in the art, various configurations to permit dose setting may be utilized. By way of non-limiting example, and with reference to <figref idref="f0007">Figures 9</figref> and <figref idref="f0004">10</figref>, a knob stem 90 may be provided with a plurality of axially and radially spaced-apart abutment surfaces 92.
0029The abutment surfaces 92 are axially alignable with an engagement surface 94 formed on the plunger 28 such that with sufficient distal displacement of the knob stem 90 at least one of the abutment surfaces 92 will be caused to engage the engagement surface 94 and transmit force of movement to the plunger 28. In this manner, distal displacement of the knob stem 90 may be transmitted to the plunger 28. Moreover, stroke length corresponding to the movement of the plunger 28 may be adjusted depending on the abutment surface 92 which is in engagement with the engagement surface 94. The greater the initial distance of the abutment surfaces 92 from the engagement surface 94, the corresponding smaller dose that will be caused to be administered. Regardless of the selected dose amount, it is preferred that the knob stem 90 having a fixed length of stroke for distal displacement during administration of an injection. The further abutment surfaces 92 have greater lost motion with distal movement of the knob stem 90 and, thus, less distance engaging the engagement surface 94. The extent of movement of the plunger 28 dictates the extent of movement of the stopper 54 and, thus, dictates the amount of the injectable solution 48 to be driven from the reservoir 46 in an injected dose.
0030The dose is selected by rotating a dose knob 96 which is fixed to the knob stem 90 so as to rotate therewith. The dose knob 96 and the knob stem 90 can be connected through any known manner, including through cooperating mechanical elements. To prevent the dose knob 96 from being inadvertently turned prior to proper preparation of the medical injector 10, such as prior to mixing of the mixable components 66, 68, assembly of the first and second body portions 12, 14, and so forth, the knob stem 90 may be coupled to the plunger 28 so as to prevent relative rotation therebetween with the plunger 28 being non-rotatably coupled to the second body portion 14. With reference to <figref idref="f0007">Figure 9</figref>, the plunger 28 may have one or more lobes 98 formed to nest in corresponding channels 100 formed in the second body portion 14. The plunger 28 may slide along the channels 100 without rotating relative thereto. In turn, the plunger 28 may have one or more internal slots 102 in which are initially nested corresponding splines 104 protruding from the plunger 28. With distal advancement of the plunger 28, the plunger 28 may decouple from the knob stem 90 so as to permit relative rotation therebetween.
0031In addition, with reference to <figref idref="f0007">Figures 9</figref> and <figref idref="f0004">10</figref>, a groove 106 may be formed in the knob stem 90 corresponding to a rib 108 formed on the plunger 28. In an initial state, the rib 108 nests within the groove 106 so as to prevent relative rotation between the plunger 28 and the knob stem 90. With distal advancement of the plunger 28 being completed, such as with completed reconstitution, the plunger 28 may be advanced so as to have the rib 108 removed from the groove 106 and to have the spline 104 removed from the internal slot 102. The knob stem 90 is then free to rotate in setting a dose. Alternatively, the rib 108 may still be partially nested in the groove 106 even after distal advancement of the plunger 28, such as to a post-reconstituted state. With this configuration, the knob stem 90 may be proximally displaced to have the rib 108 removed from the groove 106 thus permitting subsequent dose setting. The dose is administered by causing distal advancement of the knob 90 once the dose has been properly set.
0032It is noted that the engagement surface 94 may be located at a proximal end 110 of the rib 108.
0033It is preferred that the dose knob 96 be releasably retained in positions corresponding to the various dose settings. In this manner, it is preferred that once a dose has been set, there is no rotation of the dose knob 96 during distal displacement thereof, thus avoiding that an improper of the abutment surfaces 92 engage the engagement surface 94. Such an arrangement is disclosed in <patcit id="pcit0002" dnum="US6793646B"><text>U.S. Pat. No. 6,793,646</text></patcit>. As shown in <patcit id="pcit0003" dnum="US6793646B"><text>U.S. Pat. No. 6,793,646</text></patcit>, and with reference to <figref idref="f0008">Figures 11</figref> and <figref idref="f0009">12</figref>, one or more tabs 110 may be formed on the dose knob 96 which are selectively engageable with one or more positioning channels 112 formed on the second body portion 14. The positioning channels 112 may be circumferentially spaced apart and positioned to represent dose settings corresponding to the abutment surfaces 92. The tabs 110 nest in the positioning channels 112 at given radial positions of the dose knob 96 corresponding to different dose sizes. With turning of the dose knob 96, the tabs 110 are caused to by-pass the dose positioning channels 112. The positioning channels 112 maintain the radial position of the dose knob 96.
0034In addition, it is preferred that the dose knob 96 be limited in axial movement so as to permit a fixed stroke length of distal advancement for dose administration. The second body portion 14 may be provided with a reduced diameter opening 116 sized and positioned to interferingly engage the knob stem 90 upon a predetermined extent of proximal movement. The stroke of an injection is defined by the extent of proximal movement of the knob stem 90.
0035For use, the medical injector 10 is presented in the state shown in <figref idref="f0001">Figure 1</figref>, where the first and second body portions 12, 14 are separated. To prepare for use, the first and second body portions 12, 14 are moved about the coupling 16 so as to come to the assembled state shown in <figref idref="f0003">Figure 2</figref>. It is preferred that no needle be mounted to the medical injector 10 prior to assembly. With assembly, the plunger 28 is caused to be distally advanced under force of movement by the biasing element 30. Reconstitution and/or other effects are achieved through this automated movement. Thereafter, the needle 60 is mounted to the medical injector 10 as shown in <figref idref="f0008">Figure 13</figref>. The needle 60 may be provided with a cap or shield 60A. Any gases trapped in the reservoir 46 are purged through the needle 60 and the needle 60 may be primed for use.
0036With reference to <figref idref="f0010">Figures 14 and 15</figref>, a dose may be selected by proximally withdrawing the dose knob 96. Proximal withdrawal of the dose knob 96 is limited, as described above. Once withdrawn, the dose knob 96 may be rotated to a desired setting. Indicia 116 may be provided to represent doses. The indicia 116 may include numeral representations and a pointer or other indicator. With reference to <figref idref="f0010">Figure 16</figref>, the needle 60 is caused to pierce the skin of a patient and the dose knob 96 is then depressed to cause the knob stem 90 to advance distally. Interengagement between the selected of the abutment surfaces 92 and the engagement surface 94 causes the plunger 28 to drive the stopper 54 in administering an injection.
0037With the pre-use assembly of the medical injector 10, a cap 118 may be provided to cover at least partially the first and second body portions 12, 14, particularly about the coupling 16 as shown in <figref idref="f0011 f0012">Figures 17-20</figref>.
0038The cap 118 may be formed of a rigid material with a general cup shape. A loading aperture 120 may be formed in the cap 118 positioned over the first body portion 12 so as to allow the reservoir 46 to pass therethrough and be loaded into the first body portion 12. In this manner, a medical injector 10 may be stored without the reservoir 46 being located therein. The reservoir 46 may be loaded into the medical injector 10 without the cap 118 having to be removed therefrom. In addition, the cap 118 may be formed to accommodate one or more of the needles 60 therein. To maintain a clean and sterile environment within the cap 118, a sterility barrier 122, such as a removable film, is preferably provided to cover the loading aperture 120. The cap 118 may also be configured to form a tight seal about the medical injector 10. A complimentary compartment 124 may be provided with the cap 118 to wholly enclose the medical injector 10.
Contents5
12 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8 Sheet 9 Sheet 10 Sheet 11 Sheet 12
Every citation, both ways
| Document | Relation | Office |
|---|---|---|
| WO2004098687A1 | Cites | World Intellectual Property Organization (WIPO) |
| WO2005077441A2 | Cites | World Intellectual Property Organization (WIPO) |
115 members in 8 offices
Priority claims9
| Document | Office | Kind | Date |
|---|---|---|---|
| 192465P | United States of America | – | |
| 19246508 | United States of America | P | |
| 09815254 | European Patent Office (EPO) | A | |
| 2009057446 | United States of America | W | |
| US20080192465P | – | – | – |
| EP20090815254 | – | – | – |
| WO2009US57446 | – | – | – |
| 192465P | – | – | – |
| 098152549 | – | – | – |
Members115
| Document | Office | Kind | |
|---|---|---|---|
| WO2010033767A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2010033778A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2010033782A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2010033790A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2010033795A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2010033806A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2010033808A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2010033882A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2010033767A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO2010033782A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO2010033790A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO2010033795A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO2010033778A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO2010033806A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO2010033808A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO2010033882A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP2326370A2 | European Patent Office (EPO) | A2 | |
| EP2328637A2 | European Patent Office (EPO) | A2 | |
| EP2328638A2 | European Patent Office (EPO) | A2 | |
| EP2328639A2 | European Patent Office (EPO) | A2 | |
| EP2328640A2 | European Patent Office (EPO) | A2 | |
| EP2331176A2 | European Patent Office (EPO) | A2 | |
| EP2337597A2 | European Patent Office (EPO) | A2 | |
| EP2337599A2 | European Patent Office (EPO) | A2 | |
| CN102159267A | China | A | |
| US2011201999A1 | United States of America | A1 | |
| US2011202013A1 | United States of America | A1 | |
| US2011213299A1 | United States of America | A1 | |
| US2011213315A1 | United States of America | A1 | |
| CN102186516A | China | A | |
| CN102186518A | China | A | |
| CN102186519A | China | A | |
| CN102186520A | China | A | |
| CN102186521A | China | A | |
| CN102196834A | China | A | |
| CN102202710A | China | A | |
| JP2012502754A | Japan | A | |
| JP2012502757A | Japan | A | |
| JP2012502758A | Japan | A | |
| JP2012502761A | Japan | A | |
| JP2012502762A | Japan | A | |
| JP2012502764A | Japan | A | |
| JP2012502765A | Japan | A | |
| JP2012502766A | Japan | A | |
| US2012041366A1 | United States of America | A1 | |
| US2012041367A1 | United States of America | A1 | |
| US2012053516A1 | United States of America | A1 | |
| US2012184902A1 | United States of America | A1 | |
| US8323238B2 | United States of America | B2 | |
| US8403883B2 | United States of America | B2 | |
| EP2328640A4 | European Patent Office (EPO) | A4 | |
| US8486006B2 | United States of America | B2 | |
| CN102186518B | China | B | |
| CN102186521B | China | B | |
| US8500682B2 | United States of America | B2 | |
| CN102159267B | China | B | |
| CN102202710B | China | B | |
| US8556862B2 | United States of America | B2 | |
| US2013274706A1 | United States of America | A1 | |
| CN102196834B | China | B | |
| EP2328637A4 | European Patent Office (EPO) | A4 | |
| US8597245B2 | United States of America | B2 | |
| CN102186519B | China | B | |
| CN102186520B | China | B | |
| JP5373916B2 | Japan | B2 | |
| JP5379233B2 | Japan | B2 | |
| EP2326370A4 | European Patent Office (EPO) | A4 | |
| US2014074039A1 | United States of America | A1 | |
| JP5457457B2 | Japan | B2 | |
| JP5480269B2 | Japan | B2 | |
| US8728028B2 | United States of America | B2 | |
| JP5536782B2 | Japan | B2 | |
| EP2328638A4 | European Patent Office (EPO) | A4 | |
| US2014251847A1 | United States of America | A1 | |
| JP5611954B2 | Japan | B2 | |
| EP2337599A4 | European Patent Office (EPO) | A4 | |
| EP2337597A4 | European Patent Office (EPO) | A4 | |
| EP2331176A4 | European Patent Office (EPO) | A4 | |
| EP2328639A4 | European Patent Office (EPO) | A4 | |
| US2015094652A1 | United States of America | A1 | |
| US9061107B2 | United States of America | B2 | |
| CN102186516B | China | B | |
| JP5749646B2 | Japan | B2 | |
| US2015314080A1 | United States of America | A1 | |
| EP2328640B1 | European Patent Office (EPO) | B1 | |
| EP2328639B1 | European Patent Office (EPO) | B1 | |
| US2017113003A9 | United States of America | A9 | |
| DK2328639T3 | Denmark | T3 | |
| ES2619526T3 | Spain | T3 | |
| ES2625488T3 | Spain | T3 | |
| US9833577B2 | United States of America | B2 | |
| US9901681B2 | United States of America | B2 | |
| US10034980B2 | United States of America | B2 | |
| EP2337599B1 | European Patent Office (EPO) | B1 | |
| US10143808B2 | United States of America | B2 | |
| ES2709099T3 | Spain | T3 | |
| US10279125B2 | United States of America | B2 | |
| EP2337597B1 | European Patent Office (EPO) | B1 | |
| DK2337597T3 | Denmark | T3 | |
| EP3545987A1 | European Patent Office (EPO) | A1 |
73 legal events, as 11 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Full renewal or maintenance fee paidST27 STATUS EVENT CODE: U-0-0-U10-U11 (AS PROVIDED BY THE NATIONAL OFFICE)U11 | U11 | CH | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed because of non-payment of the annual feeLapsedMM | MM | BE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| No opposition filedOpposition26N | 26N | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| No opposition filed against granted patent, or epo opposition proceedings concluded without decisionGrantedR097 | R097 | DE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Invalidation of extension of european patentsMG9D | MG9D | LT | |
| Translation of granted ep patentGrantedTRGR | TRGR | SE | |
| Ep patent with danish claimsT3 | T3 | DK | |
| Translation for ep filed (entry of ep into country)FP | FP | NL | |
| New agentNV | NV | CH | |
| Information on inventor provided after grant (corrected)RIN2 | RIN2 | EP | |
| Information on inventor provided after grant (corrected)RIN2 | RIN2 | EP | |
| Information on inventor provided after grant (corrected)RIN2 | RIN2 | EP | |
| Information on inventor provided after grant (corrected)RIN2 | RIN2 | EP | |
| European patents granted designating irelandGrantedFG4D | FG4D | IE | |
| Reference to at number (ep patent validated in austria)REF | REF | AT | |
| Dpma publication of mentioned ep patent grantGrantedR096 | R096 | DE | |
| European patent takes effect as a national patent in ch/liEP | EP | CH | |
| CorrectionBERICHTIGUNGENPK | PK | CH | |
| Divisional application: reference to earlier applicationAC | AC | EP | |
| Designated contracting statesAK | AK | EP | |
| European patent grantedGrantedFG4D | FG4D | GB | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE PATENT HAS BEEN GRANTEDSTAA | STAA | EP | |
| Grant fee paidORIGINAL CODE: EPIDOSNIGR3GRAS | GRAS | EP | |
| Intention to grant announcedINTG | INTG | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP | GRAP | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: GRANT OF PATENT IS INTENDEDSTAA | STAA | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting states (corrected)RBV | RBV | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: REQUEST FOR EXAMINATION WAS MADESTAA | STAA | EP | |
| Divisional application: reference to earlier applicationAC | AC | EP | |
| Designated contracting statesAK | AK | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE APPLICATION HAS BEEN PUBLISHEDSTAA | STAA | EP |
Numbers
- Publication
- 3545987
- Publication, DOCDB
- 3545987
- Publication, EPODOC
- EP3545987
- Application
- 191730324
- Application, DOCDB
- 19173032
- Application, EPODOC
- EP20190173032
Titles3
- German
- MEDIZINISCHER INJEKTOR MIT GEKOPPELTEN KÖRPERELEMENTEN
- English
- MEDICAL INJECTOR WITH COUPLED BODY PORTIONS
- French
- INJECTEUR MÉDICAL À PARTIES DE CORPS COUPLÉES
Classification
- CPC, 6
- A61M5/3205
- A61M5/3158
- A61M2005/2407
- A61M2005/2496
- A61M5/002
- A61M5/3213
- IPC, 8
- A61M5 178
- A61M5 32
- A61M5 24
- A61M5 20
- A61M5 31
- A61M5 34
- A61M5 00
- A61M5 315
Designated states1
- Contracting states, 1
- Türkiye
